GPT Healthcare

Healthcare Services

GPTHEALTH NSE

NSE: GPTHEALTH BSE: 544131 Hospitals

₹141.04 No trade today

P/E: 24.49

View as Markdown

MCP

Close 4 Nov 2026 ₹141.04 −4.38 −3.01% 1Y

Start ₹145.42

Key Fundamentals

MicrocapHealthcare ServicesHealthcare

Price-based figures as of 04 Nov 2026, 15:29 IST · EPS basis: Standalone · TTM

ROCE: 19.90%
Debt to Equity: 0.34
EPS (TTM): ₹5.76
Book Value: ₹32.84

Market Cap: —
P/E (TTM): 24.49
P/B: 4.29
ROE: 16.70%
Dividend Yield: 1.82%
EBITDA: ₹78.80 Cr
52W High: ₹175.00
52W Low: ₹115.00
Volume: 0

Peer Comparison

Healthcare › Healthcare Services › Hospitals › Hospital

GPT Healthcare peer comparison

Apollo Hospitals	₹8,599.50	59.18	₹1,22,850 Cr	13.04	0.24%	21.20%	17.40%	₹26,430 Cr	₹2,171 Cr
Max Healthcare Institute	₹927.15	61.89	₹89,301 Cr	7.96	0.22%	14.70%	14.70%	₹8,712 Cr	₹1,457 Cr
Manipal Health Enterprises	₹667.20	88.96	₹86,479 Cr	5.34	0.00%	6.64%	8.30%	₹11,400 Cr	₹906 Cr
Aster DM Healthcare	₹719.55	117.00	₹59,927 Cr	14.91	0.44%	11.30%	11.60%	₹4,876 Cr	₹363 Cr
Fortis Healthcare	₹790.65	56.96	₹59,706 Cr	6.03	0.13%	11.20%	13.40%	₹9,506 Cr	₹1,070 Cr
Narayana Hrudayalaya	₹1,931.50	48.36	₹39,090 Cr	7.89	0.24%	20.50%	15.50%	₹9,072 Cr	₹816 Cr
Global Health	₹1,402.00	67.76	₹37,618 Cr	9.52	0.04%	15.20%	17.40%	₹4,683 Cr	₹552 Cr
GPT Healthcare (this company)	₹141.04	24.49	₹1,136 Cr	4.29	1.82%	16.70%	19.90%	₹492 Cr	₹48 Cr
Median 8 companies	₹858.90	60.54	₹59,817 Cr	7.93	0.23%	14.95%	15.10%	₹8,892 Cr	₹861 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of 4 Nov 2026. How it works →

Overall score

60 Good

Data confidence 100/100

Category scores

Quality: 68; Strong; Returns, margins, earnings quality 22% weight
Valuation: 70; Strong; Cheap vs sector & own history 24% weight
Growth: 64; Good; Sales & profit trajectory 9% weight
Financial Health: 43; Weak; Solvency, leverage, coverage 9% weight
Momentum: 33; Poor; Trend strength, vol-adjusted 12% weight
Ownership: 55; Average; FII/DII/promoter flows 24% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

Company has been maintaining a healthy dividend payout of 49.9%

No weaknesses listed

Technical Indicators

Technical signals: verdict and indicator counts
Group	Signal	Bearish	Neutral	Bullish
Overall	Bearish	8	4	7
Oscillators	Bullish	2	4	3
Moving Averages	Strong Bearish	6	0	4

Oscillators

Bullish

Bearish

Neutral

Bullish

Overall

Bearish

Neutral

Bullish

Moving Averages

Strong Bearish

Bearish

Neutral

Bullish

Key readings

RSI (14): 49.53; Neutral
MACD (12,26,9): −3.95; Bullish
SMA (50): 149.15; Bearish
SMA (200): 142.50; Bearish

As of 4 Nov 2026

Growth Rate

From the financial statements below. 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.

Revenue

Revenue growth by window
5Y	+14.25%
3Y	+9.43%
1Y	+16.22%
TTM	+18.03%

Net profit

Net profit growth by window
5Y	+14.87%
3Y	+2.50%
1Y	−16.00%
TTM	0.00%

Operating cash flow

Operating cash flow growth by window
5Y	+13.50%
3Y	+7.06%
1Y	+20.90%
TTM	—

TTM: Reported once a year, so there is no trailing-twelve-month figure.

Operating margin· change in pp

Operating margin growth by window
5Y	−2.19 pp
3Y	−2.53 pp
1Y	−2.42 pp
TTM	−1.18 pp

Revenue by year

Revenue by year, ₹ crore
Mar 2020	₹212 Cr
Mar 2021	₹243 Cr
Mar 2022	₹337 Cr
Mar 2023	₹361 Cr
Mar 2024	₹400 Cr
Mar 2025	₹407 Cr
Mar 2026	₹473 Cr

Net profit by year

Net profit by year, ₹ crore
Mar 2020	₹11.00 Cr
Mar 2021	₹21.00 Cr
Mar 2022	₹42.00 Cr
Mar 2023	₹39.00 Cr
Mar 2024	₹48.00 Cr
Mar 2025	₹50.00 Cr
Mar 2026	₹42.00 Cr

Analyst Forecasts

Forecast For

Mar 27 consensus · Price

₹136.00 −9.8% vs Sep 26

Reported High Mean Low

Quarterly Results

₹ Cr

GPTHEALTH quarterly results, ₹ crore
Particulars	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	96	108	97	99	98	106	102	101	107	119	120	126	126
Expenses	77	83	76	76	80	82	81	81	90	96	99	103	102
Operating Profit	19	25	21	23	18	23	21	21	17	23	21	23	24
OPM %	20%	23%	22%	23%	18%	22%	21%	20%	16%	19%	17%	18%	19%
Other Income	1	1	1	2	2	3	2	2	2	1	1	2	2
Interest	2	2	2	2	1	1	1	1	2	2	2	2	2
Depreciation	4	4	4	5	5	5	5	5	6	7	7	7	7
PBT	14	19	16	18	15	21	18	16	11	15	13	16	17
Tax %	30%	31%	28%	30%	32%	28%	30%	21%	31%	30%	27%	8%	26%
Net Profit	10	14	11	13	10	15	12	13	8	11	9	15	13
EPS (₹)	1.25	1.69	1.44	1.56	1.21	1.81	1.49	1.57	0.94	1.29	1.14	1.78	1.55

Profit & Loss

₹ Cr

GPTHEALTH profit and loss, annual, ₹ crore
Particulars	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	212	243	337	361	400	407	473	492
Expenses	176	194	263	287	312	324	387	401
Operating Profit	36	49	74	74	88	83	85	91
OPM %	17%	20%	22%	21%	22%	20%	18%	19%
Other Income	4	6	5	6	5	8	5.95	6
Interest	14	14	11	9	7	3	8	9
Depreciation	11	12	14	15	18	19	27	28
PBT	15	29	54	56	68	69	55	61
Tax %	26%	27%	23%	30%	30%	28%	23%	—
Net Profit	11	21	42	39	48	50	42	47
EPS (₹)	6.11	11.76	5.21	4.88	5.82	6.08	5.15	5.76
Div. Payout %	0%	47%	0%	102%	60%	41%	49%	—

Balance Sheet

₹ Cr

GPTHEALTH balance sheet, annual, ₹ crore
Particulars	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	18	18	80	80	82	82	82
Reserves	109	116	78	85	136	166	187
Borrowings	157	166	102	82	31	35	91
Other Liabilities	25	18	63	79	96	101	104
Total Liabilities	308	317	323	327	346	384	465
Fixed Assets	226	220	220	228	224	228	342
CWIP	2	0	1	3	6	46	1
Investments	1	1	10	13	30	32	43
Other Assets	80	97	92	83	85	78	79
Total Assets	308	317	323	327	346	384	465

Cash Flow

₹ Cr

GPTHEALTH cash flow, annual, ₹ crore
Particulars	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Operating	41	43	66	66	69	67	81
Investing	−54	−16	−5	5	−25	−33	−47
Financing	12	−22	−57	−73	−48	−35	−31
Net Cash Flow	−1	4	3	−2	−5	0	2
Free Cash Flow	−5	38	59	58	50	18	40
CFO/OP	116	88	107	103	95	101	110

Ratios

GPTHEALTH financial ratios, annual
Particulars	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	30	26	15	21	22	18	16
Inventory Days	60	41	30	43	36	41	43
Days Payable	314	165	121	161	165	161	170
Cash Conversion Cycle	−224	−98	−76	−97	−106	−102	−112
Working Capital Days	−4	32	3	−18	−16	−28	−29
ROCE %	—	14%	23%	25%	30%	27%	20%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

62 extracted metrics across FY20–FY27.

Shareholding Pattern

As of Sep 2026

Promoters 65.57%
Public 18.10%
DIIs 7.10%
Others 6.22%
FIIs 3.00%

No promoter shares pledged as of 14 Oct 2026

Change vs previous quarter

Documents

Q1 FY27 concall · Aug 2026
Transcript PPT Recording
Q4 FY26 concall · May 2026
Transcript PPT
Q3 FY26 concall · Feb 2026
Transcript PPT
Q2 FY26 concall · Nov 2025
Transcript PPT Recording
Q1 FY26 concall · Aug 2025
Transcript PPT

Frequently Asked Questions about GPT Healthcare

What does GPT Healthcare Ltd do?

Incorporated in 1989, GPT Healthcare Ltd is engaged in running hospitals and providing medical services

Where is GPT Healthcare Ltd (GPTHEALTH) listed?

GPT Healthcare Ltd trades as GPTHEALTH on the NSE and under code 544131 on the BSE.

Which sector does GPT Healthcare Ltd belong to?

GPT Healthcare Ltd is classified under the Healthcare Services sector, in the Hospitals industry.

What is the PE ratio of GPT Healthcare Ltd?

GPT Healthcare Ltd trades at a PE ratio of 24.49 as of 4 Nov 2026, on earnings per share of ₹5.76, against a book value of ₹32.84 per share.

What is the 52-week high and low of GPT Healthcare Ltd?

Over the last 52 weeks GPT Healthcare Ltd has traded between ₹115 and ₹175 as of 4 Nov 2026.

Does GPT Healthcare Ltd pay dividends?

GPT Healthcare Ltd has a dividend yield of 1.82%.

What is the Return on Equity (ROE) of GPT Healthcare Ltd?

GPT Healthcare Ltd reported a return on equity of 16.70%. Its debt-to-equity ratio is 0.34.

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/GPTHEALTH.md for GPT Healthcare Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List FII and DII flows, month by month How Tapetide Scores changed, month by month Stocks mutual funds are buying, month by month

GPT Healthcare

Key Fundamentals

Peer Comparison

Overall score

Category scores

Key Insights

Strengths

Technical Indicators

Oscillators

Overall

Moving Averages

Key readings

Growth Rate

Revenue

Net profit

Operating cash flow

Operating margin· change in pp

Revenue by year

Net profit by year

Analyst Forecasts

Quarterly Results

Profit & Loss

Balance Sheet

Cash Flow

Ratios

Insights

Shareholding Pattern

Documents

Frequently Asked Questions about GPT Healthcare

Company Information

For AI agents and developers

Explore More